Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Prospective Observation on the Use of Von Willebrand Factor (VWF) Concentrates in a Large Cohort of Type 3 Von Willebrand Disease (VWD): Interim (18-months) Analyses on 149 Cases Enrolled into the 3Winters-Ips Project

Blood (2018) 132 (Supplement 1): 2464.

https://doi.org/10.1182/blood-2018-99-112447

Published: 2018

Journal Articles

Clustering of Bleeding Symptoms in Patients Previously Diagnosed As Type 3 Von Willebrand Disease: Results from a Large Cohort of Type 3 Von Willebrand Disease (the 3Winters-Ips Project)

Blood (2018) 132 (Supplement 1): 2465.

https://doi.org/10.1182/blood-2018-99-113996

Published: 2018

Journal Articles

Profile of Mutations Identified in the 3WINTERS-IPS Project on European & Iranian Patients with Previously Diagnosed Type 3 Von Willebrand Disease.

Luciano Baronciani, PhD, Flora Peyvandi, MD PhD, Anne Goodeve, PhD, Reinhard Schneppenheim, MDPhD, Zahra Badiee, Mohammad-Reza Baghaipour, Javier Battle, Erik Berntorp, MD PhD, Imre Bodó, MD PhD, Ulrich Budde, MD, Andrea Cairo, PhD, Giancarlo Castaman, Laura Crookes, Jeroen C.J. Eikenboom, MD, Peyman Eshghi, MD, Cosimo Ettorre, MD, Jenny Goudemand, MD PhD, Wolf Hassenpflug, Charles Richard Morris Hay, MDFRCP,FRCPath, Hamid Hoorfar, MD, Mehran Karimi, MD, Bijan Keikhaei, Riitta Lassila, MD PR, Frank W.G. Leebeek, MD PhD, Maria Fernanda Lopez Fernandez, Pier Mannuccio Mannucci, MD, Maria Gabriella Mazzucconi, MD, Massimo Morfini, MD, Nikolas Nikšić, Johannes Oldenburg, Florian Oyen, Rafael Parra Lòpez, Ian Peake, PhD, Gholamreza Toogeh, Alberto Tosetto, Marc Trossaert, Sayed Omid Reza Zekavat, MD, Eva M.K. Zetterberg, MD PhD, Augusto B Federici, MD

Blood (2018) 132 (Supplement 1): 1184.

https://doi.org/10.1182/blood-2018-99-114702

Published: 2018

Journal Articles

Imbalance between ADAMTS13 and VWF Activities Might Identify Thrombotic of Bleeding Events in Essential Thrombocythemia (ET): Results from a Cohort of 72 Cases.

Augusto B Federici, MD, Orazio Di Bartolo, MD, Stefania Agnoli, MD, Daniela Intini, Antonella Lattuada, Mariacristina Carraro

Blood (2017) 130 (Supplement 1): 5277.

https://doi.org/10.1182/blood.V130.Suppl_1.5277.5277

Published: 2017

Journal Articles

Platelet Cut-Off For Anticoagulant Therapy In Cancer Patients With Venous Thromboembolism and Thrombocytopenia: An Expert Opinion Based On RAND/UCLA Appropriateness Method (RAM)

Giorgia Saccullo, MD, Marco Marietta, Monica Carpenedo, Valerio De Stefano, MD, Anna Falanga, Augusto B. Federici, MD, Francesco Rodeghiero, Alberto Tosetto, M.D., Sergio Siragusa, MD

Blood (2013) 122 (21): 581.

https://doi.org/10.1182/blood.V122.21.581.581

Published: 2013

Journal Articles

Frequency and Determinants of Thrombotic and Bleeding Complications in Ph Negative Myeloproliferative Neoplasms (MPN): The Role of Adamts-13 and VWF Activities in an Italian Cohort 0f 88 Well Characterized Patients

Augusto B. Federici, MD, Maria C Carraro, Antonella Lattuada, Chiara Vanelli, Veronica Sciumbata, Valentina Rossi, MD, Daniela Intini, Sarah Birindelli, Sara Munizza, Elisabetta Sacchi, Umberto Russo, Ulrich Budde, MD

Blood (2012) 120 (21): 3369.

https://doi.org/10.1182/blood.V120.21.3369.3369

Published: 2012

Journal Articles

Intracellular Retention, Enhanced Clearance, and Defective FVIII Binding Are Common Features of Von Willebrand Factor D'-D3 Domain Mutations in Patients with Von Willebrand Disease Type 1 From the European Mcmdm-1VWD Study

Reinhard Schneppenheim, MD, PhD, Ulrich Budde, MD, Javier Batlle, MD, Giancarlo Castaman, MD, Jeroen C. J. Eikenboom, MD, PhD, Augusto B. Federici, MD, Jenny Goudemand, MD, PhD, Tobias Obser, Florian Oyen, Francesco Rodeghiero, MD, Sonja Schneppenheim, MD, Ian R. Peake, PhD, Anne C. Goodeve, PhD

Blood (2012) 120 (21): 99.

https://doi.org/10.1182/blood.V120.21.99.99

Published: 2012

Journal Articles

Clinical Use of a Von Willebrand Factor with a Low FVIII Content in Von Willebrand Disease Patients Undergoing Surgical Procedures or Deliveries: Results From 5 Prospective Multicenter Studies

Annie Borel-Derlon, MD, PhD, Augusto B. Federici, MD, Jenny Goudemand, MD, PhD, Catherine Chatelanaz, Celine Henriet, Françoise Bridey

Blood (2011) 118 (21): 383.

https://doi.org/10.1182/blood.V118.21.383.383

Published: 2011

Journal Articles

Lymphoproliferative Disorder and Acquired C1-INH Deficiency. A Case Series of 48 Patients

Fabrizio Foieni, MD, Andrea Zanichelli, MD, Anna Coerezza, MD, Roberto Castelli, MD, Lorena Maggioni, PhD, Chiara Suffritti, PhD, Erika Bonanni, Augusto B. Federici, MD, Marco Cicardi, MD

Blood (2011) 118 (21): 1596.

https://doi.org/10.1182/blood.V118.21.1596.1596

Published: 2011

Journal Articles

A Two-Year Prospective Study on Bleeding Tendency In 105 Patients with Type 2 A and M Von Willebrand Disease

Giancarlo Castaman, MD, Augusto B. Federici, MD, Luciano Baronciani, Pier M. Mannucci, MD, Francesco Rodeghiero

Blood (2010) 116 (21): 543.

https://doi.org/10.1182/blood.V116.21.543.543

Published: 2010

Journal Articles

Regular Replacement Therapy as Prophylaxis In Severe Forms of Von Willebrand Disease: Initial Results From the Von Willebrand Disease Prophylaxis Network (VWD PN) Study Group

Erik Berntorp, MD, PhD, Thomas C. Abshire, MD, Augusto B. Federici, MD

Blood (2010) 116 (21): 236.

https://doi.org/10.1182/blood.V116.21.236.236

Published: 2010

Journal Articles

Clinical Efficacy and Safety Versus Biological Response of Desmopressin (DDAVP) In Inherited Von Willebrand Disease (VWD) Types 1 and 2: Initial Results From the International Study Group on DDAVP In VWD In a Cohort of 229 Patients

Augusto B. Federici, MD, Alfonso Iorio, MD, Giancarlo Castaman, MD

Blood (2010) 116 (21): 238.

https://doi.org/10.1182/blood.V116.21.238.238

Published: 2010

Journal Articles

Cytoreductive Therapeutic Approach in the Essential Thrombocythemia (ET) Patients of the Registro Italiano Trombocitemia (RIT): Preliminary Data

Blood (2008) 112 (11): 5248.

https://doi.org/10.1182/blood.V112.11.5248.5248

Published: 2008

Journal Articles

Circulating Versus Progenitor Endothelial Cells Levels Are Abnormal in Patients with Different Types of Von Willebrand Disease and Correlate with Markers of Angiogenesis

Giuseppe Gritti, MD, Augusto B Federici, MD, Agostino Cortelezzi, MD, Luciano Baronciani, PhD, Silvia Lonati, PhD, Margherita Punzo, Ilaria Silvestris, Rosanna Garavaglia, MD, Giorgio Lambertenghi, MD, Pier M Mannucci, MD

Blood (2008) 112 (11): 5457.

https://doi.org/10.1182/blood.V112.11.5457.5457

Published: 2008

Journal Articles

Relevance of Chloride Binding to Von Willebrand Factor in Type 2B Von Willebrand Disease Patients.

Luciano Baronciani, PhD, Flora Peyvandi, MD, Margherita Punzo, PhD, Maria T. Canciani, PhD, Enrico Di Stasio, MD, Augusto B. Federici, MD, Pier M. Mannucci, MD, Raimondo De Cristofaro, MD

Blood (2008) 112 (11): 3384.

https://doi.org/10.1182/blood.V112.11.3384.3384

Published: 2008

Journal Articles

Abnormal Large Platelets Are Associated Not Only with von Willebrand Disease (VWD) Type 2B (Including Type 2B/1 New York) but Also with Severe Type 3: A Potential Role for von Willebrand Factor (VWF) in Megakaryocytopoiesis.

Paquita Nurden, MD, PhD, Alan T. Nurden, PhD, Jocelyne Enouf, PhD, Silvia La Marca, Luciano Baronciani, Augusto B. Federici, MD, PhD

Blood (2007) 110 (11): 101.

https://doi.org/10.1182/blood.V110.11.101.101

Published: 2007

Journal Articles

Type 2B “Malmo/New York” Is Not So Rare among Italian Patients with von Willebrand Disease: The Role of P1266L/Q Mutations of the von Willebrand Factor Gene in Seven Cases.

Luciano Baronciani, PhD, Silvia La Marca, PhD, Giancarlo Castaman, MD, Margherita Punzo, PhD, Rosanna Garavaglia, MD, Valentina Rubini, PhD, Giovanna Cozzi, PhD, Maria T. Canciani, PhD, Augusto B. Federici, MD

Blood (2007) 110 (11): 712.

https://doi.org/10.1182/blood.V110.11.712.712

Published: 2007

Journal Articles

Incidence and Determinants of Bleeding in Different Types of von Willebrand Disease: Results of the First Prospective Multicenter Study on 814 Italian Patients.

Augusto B. Federici, MD, Paolo Bucciarelli, MD, Giancarlo Castaman, MD, Maria G. Mazzucconi, MD, Massimo Morfini, MD, Angiola Rocino, MD, Mario Schiavoni, MD, Francesco Rodeghiero, MD, Pier M. Mannucci, MD

Blood (2007) 110 (11): 713.

https://doi.org/10.1182/blood.V110.11.713.713

Published: 2007

Journal Articles

Molecular Mapping of the Chloride Binding Site in von Willebrand Factor (VWF): Energetics and Conformational Effects on the ADAMTS-13 Interaction with Wild Type and Type 2B R1306W VWF Forms.

Raimondo De Cristofaro, MD, Flora Peyvandi, MD, Luciano Baronciani, PhD, Roberta Palla, PhD, Silvia Lavoretano, PhD, Rossana Lombardi, PhD, Enrico Di Stasio, MD, Augusto B. Federici, MD, Pier Mannuccio Mannucci, MD

Blood (2006) 108 (11): 333.

https://doi.org/10.1182/blood.V108.11.333.333

Published: 2006

Journal Articles

Studies with the Nanobody That Detects the Gain-of-Function of von Willebrand Factor in a Cohort of Patients with Type 2B von Willebrand Disease: Correlation with Platelet Count, VWF Multimers and Molecular Defects.

Augusto B. Federici, MD, Luciano Baronciani, PhD, Maria T. Canciani, PhD, Barbara Moroni, PhD, Carlo Balduini, MD, Pier M. Mannucci, MD, Peter J. Lenting, PhD, Philip G. de Groot, PhD

Blood (2006) 108 (11): 1011.

https://doi.org/10.1182/blood.V108.11.1011.1011

Published: 2006

NARROW

Prospective Observation on the Use of Von Willebrand Factor (VWF) Concentrates in a Large Cohort of Type 3 Von Willebrand Disease (VWD): Interim (18-months) Analyses on 149 Cases Enrolled into the 3Winters-Ips Project

Clustering of Bleeding Symptoms in Patients Previously Diagnosed As Type 3 Von Willebrand Disease: Results from a Large Cohort of Type 3 Von Willebrand Disease (the 3Winters-Ips Project)

Profile of Mutations Identified in the 3WINTERS-IPS Project on European & Iranian Patients with Previously Diagnosed Type 3 Von Willebrand Disease.

Imbalance between ADAMTS13 and VWF Activities Might Identify Thrombotic of Bleeding Events in Essential Thrombocythemia (ET): Results from a Cohort of 72 Cases.

Platelet Cut-Off For Anticoagulant Therapy In Cancer Patients With Venous Thromboembolism and Thrombocytopenia: An Expert Opinion Based On RAND/UCLA Appropriateness Method (RAM)

Frequency and Determinants of Thrombotic and Bleeding Complications in Ph Negative Myeloproliferative Neoplasms (MPN): The Role of Adamts-13 and VWF Activities in an Italian Cohort 0f 88 Well Characterized Patients

Intracellular Retention, Enhanced Clearance, and Defective FVIII Binding Are Common Features of Von Willebrand Factor D'-D3 Domain Mutations in Patients with Von Willebrand Disease Type 1 From the European Mcmdm-1VWD Study

Clinical Use of a Von Willebrand Factor with a Low FVIII Content in Von Willebrand Disease Patients Undergoing Surgical Procedures or Deliveries: Results From 5 Prospective Multicenter Studies

Lymphoproliferative Disorder and Acquired C1-INH Deficiency. A Case Series of 48 Patients

A Two-Year Prospective Study on Bleeding Tendency In 105 Patients with Type 2 A and M Von Willebrand Disease

Regular Replacement Therapy as Prophylaxis In Severe Forms of Von Willebrand Disease: Initial Results From the Von Willebrand Disease Prophylaxis Network (VWD PN) Study Group

Clinical Efficacy and Safety Versus Biological Response of Desmopressin (DDAVP) In Inherited Von Willebrand Disease (VWD) Types 1 and 2: Initial Results From the International Study Group on DDAVP In VWD In a Cohort of 229 Patients

Cytoreductive Therapeutic Approach in the Essential Thrombocythemia (ET) Patients of the Registro Italiano Trombocitemia (RIT): Preliminary Data

Circulating Versus Progenitor Endothelial Cells Levels Are Abnormal in Patients with Different Types of Von Willebrand Disease and Correlate with Markers of Angiogenesis

Relevance of Chloride Binding to Von Willebrand Factor in Type 2B Von Willebrand Disease Patients.

Abnormal Large Platelets Are Associated Not Only with von Willebrand Disease (VWD) Type 2B (Including Type 2B/1 New York) but Also with Severe Type 3: A Potential Role for von Willebrand Factor (VWF) in Megakaryocytopoiesis.

Type 2B “Malmo/New York” Is Not So Rare among Italian Patients with von Willebrand Disease: The Role of P1266L/Q Mutations of the von Willebrand Factor Gene in Seven Cases.

Incidence and Determinants of Bleeding in Different Types of von Willebrand Disease: Results of the First Prospective Multicenter Study on 814 Italian Patients.

Molecular Mapping of the Chloride Binding Site in von Willebrand Factor (VWF): Energetics and Conformational Effects on the ADAMTS-13 Interaction with Wild Type and Type 2B R1306W VWF Forms.

Studies with the Nanobody That Detects the Gain-of-Function of von Willebrand Factor in a Cohort of Patients with Type 2B von Willebrand Disease: Correlation with Platelet Count, VWF Multimers and Molecular Defects.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only